[The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
Skvortsova. R G RG; Nikitina. O I OI
Key Findings
- Thymalin plus T‑activin shifted lymphocyte subpopulation ratios toward normal in TB patients
- The shift was associated with improved clinical condition
- Cellular electrophoresis was used to monitor these immune changes
Practical Outcomes
- Thymalin shows some promise as an immune‑modulating agent, but the evidence is limited to a specific disease context and lacks practical dosing or safety data. For biohackers, it’s an interesting lead but not ready for self‑experimentation or general longevity protocols.
Summary
A study on lung TB patients found that adding the peptide thymalin (with T‑activin) helped balance certain immune cells in the blood and was linked to better health outcomes, but the research was done on sick patients, gave no dosage details, and used lab‑based measurements that aren’t easy to replicate at home.
Abstract
The monitoring of the immune system in pulmonary tuberculosis patients and their peripheric blood lymphocyte reaction to its T-system modulators was undertaken by cellular electrophoresis. It was shown that when the lymphocyte subpopulation ratio tends to be normalized in vitro by inoculation with thymalin and T-activin, the given situation can be viewed as an indication to prescribe immunocorrection drugs to these patients. The lymphocyte subpopulation ratio check in the pulmonary tuberculosis subjects by means of the proposed method before and after the thymalin and T-activin treatment made it possible to reveal a significant normalization of the immunologic indices and to achieve better clinical condition of the patients.
Study Information
pubmed
1990